يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"PROTEIN overexpression"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1
    تقرير
    Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

    المؤلفون: AstraZeneca

    المصدر: BrUOG 413: A Phase II Study of Adjuvant Trastuzumab Deruxtecan (Enhertu) + Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2-Positive Cancers of the Esophagus and Gastroesophageal Junction

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05480384Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
  2. 2
    تقرير
    Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

    المصدر: A Phase 1/2a, Open-Label, Multi-Center Study Evaluating the Safety and Anti-Tumor Activity of Ex Vivo Expanded, Autologous Natural Killer Cells (SNK01) in Combination With Trastuzumab or Cetuximab in Subjects With Advanced/Metastatic HER2- or EGFR-Expressing Cancers

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04464967Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث